Abstract
COPD is a condition characterized by progressive airflow obstruction which is rather insensible to bronchodilators. The pathogenetic mechanisms of this disorder are multifaceted, encompassing pulmonary inflammation, small airway remodelling, emphysema and mucous hypersecretion. As our comprehension of the heterogeneous pathology of the disease has improved it has been recognized that the ongoing inflammatory process in COPD is correlated with the relentlessness of this condition. Therefore, the scientific interest has been directed in the development of new anti-inflammatory drugs targeting pulmonary inflammation. In this survey, we will try to evaluate current treatment options and the potential and efficacy of new treatment modalities.
Current Respiratory Medicine Reviews
Title: COPD: Optimal Current Treatment Strategies and Promising New Therapeutic Modalities
Volume: 5 Issue: 2
Author(s): Ioannis Starakis
Affiliation:
Abstract: COPD is a condition characterized by progressive airflow obstruction which is rather insensible to bronchodilators. The pathogenetic mechanisms of this disorder are multifaceted, encompassing pulmonary inflammation, small airway remodelling, emphysema and mucous hypersecretion. As our comprehension of the heterogeneous pathology of the disease has improved it has been recognized that the ongoing inflammatory process in COPD is correlated with the relentlessness of this condition. Therefore, the scientific interest has been directed in the development of new anti-inflammatory drugs targeting pulmonary inflammation. In this survey, we will try to evaluate current treatment options and the potential and efficacy of new treatment modalities.
Export Options
About this article
Cite this article as:
Starakis Ioannis, COPD: Optimal Current Treatment Strategies and Promising New Therapeutic Modalities, Current Respiratory Medicine Reviews 2009; 5 (2) . https://dx.doi.org/10.2174/157339809788189923
DOI https://dx.doi.org/10.2174/157339809788189923 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Current Molecular Medicine Community-Acquired Pneumonia in Children
Recent Patents on Inflammation & Allergy Drug Discovery Catestatin: A Master Regulator of Cardiovascular Functions
Current Medicinal Chemistry Obesity and Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Are Patient Self-Report Questionnaires as "Scientific" as Biomarkers in "Treat-totarget" and Prognosis in Rheumatoid Arthritis?
Current Pharmaceutical Design Challenges and Controversies in Autoantibodies Associated with Systemic Rheumatic Diseases
Current Rheumatology Reviews The Potential of Microalgae for the Production of Bioactive Molecules of Pharmaceutical Interest
Current Pharmaceutical Biotechnology Concerns and Hopes for Stem Cell Therapy in Cardiology: Focus on Endothelial Progenitor Cells
Cardiovascular & Hematological Disorders-Drug Targets Mitochondrial Dysfunction and Antioxidant Therapy in Sepsis
Infectious Disorders - Drug Targets Cell Sheet Technology for Heart Failure
Current Pharmaceutical Biotechnology Levosimendan for Heart-Operated Patients: What is the State of the Art?
Recent Patents on Cardiovascular Drug Discovery Lifestyle Modifications in the Treatment of Hypertension
Current Hypertension Reviews Micronutrient Intake in the Etiology, Prevention and Treatment of Osteosarcopenic Obesity
Current Aging Science The Use of Novel Oral Anticoagulants in Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets Cardiac Calmodulin Kinase: A Potential Target for Drug Design
Current Medicinal Chemistry Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?
Current Vascular Pharmacology Alcohol Induced Hepato Cardiotoxicity and Oxidative Damage in Rats: The Protective Effect of n-butanol Extract of Green Tea (Camellia sinensis (L.) Kuntze)
Cardiovascular & Hematological Disorders-Drug Targets Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research
Current Alzheimer Research Exploration of the Medicinal Peptide Space
Protein & Peptide Letters Experimental Animal Models of Myocardial Damage in Regenerative Medicine Studies Involving Adult Bone Marrow Derived Stem Cells: Ethical and Methodological Implications
Cardiovascular & Hematological Disorders-Drug Targets